Literature DB >> 2958041

Effects of intravascular contrast media on blood-brain barrier. Comparison between iothalamate, iohexol, iopentol and iodixanol.

A Aulie Michelet1.   

Abstract

The effects upon the rabbit blood-brain barrier after intracarotid injection of two non-ionic contrast media, iopentol (a monomer) and iodixanol (a dimer) were compared. Iothalamate and iohexol were used as reference substances. 99Tcm-DTPA, 125I-HSA and Trypsin blue were used as tracers in order to demonstrate various degrees of damage to the barrier. Injection of iothalamate led to large extravasation of 99Tcm-DTPA, 125I-HSA and Trypan blue which means severe damage of the blood-brain barrier. Injection of iopentol and iohexol resulted in some extravasation of all three tracers used, whereas injection of iodixanol only led to extravasation of the small molecule tracer 99Tcm-DTPA demonstrating minor changes of the barrier. At computed tomography of the brain with intravascular contrast medium enhancement it is safer to use iodixanol than iothalamate. Iodixanol is expected to cause even less adverse effects to the brain after intraarterial injection than iopentol and iohexol.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2958041

Source DB:  PubMed          Journal:  Acta Radiol        ISSN: 0284-1851            Impact factor:   1.990


  4 in total

Review 1.  The non-ionic isotonic contrast agents. Perspectives and controversies.

Authors:  P Dawson
Journal:  Eur Radiol       Date:  1996       Impact factor: 5.315

2.  Decreased infarct volume and intracranial hemorrhage associated with intra-arterial nonionic iso-osmolar contrast material in an MCA occlusion/reperfusion model.

Authors:  H Morales; A Lu; Y Kurosawa; J F Clark; J Leach; K Weiss; T Tomsick
Journal:  AJNR Am J Neuroradiol       Date:  2014-05-08       Impact factor: 3.825

3.  Outcome Differences between Intra-Arterial Iso- and Low-Osmolality Iodinated Radiographic Contrast Media in the Interventional Management of Stroke III Trial.

Authors:  T A Tomsick; L D Foster; D S Liebeskind; M D Hill; J Carrozella; M Goyal; R von Kummer; A M Demchuk; I Dzialowski; V Puetz; T Jovin; H Morales; Y Y Palesch; J Broderick; P Khatri; S D Yeatts
Journal:  AJNR Am J Neuroradiol       Date:  2015-07-30       Impact factor: 3.825

4.  Preclinical safety assessment of contrast media: predictive value.

Authors:  J O Karlsson
Journal:  Eur Radiol       Date:  1996       Impact factor: 5.315

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.